# Dynamic RegeTissue

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dynamic-regetissue

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Latest round: Angel (Jan 4, 2026)
- Investors on record: 1

## About

Founded in 2025 and based in Shanghai, China, PowerMicro Officer (Shanghai) Biotechnology Co., Ltd., trading as Dynamic RegeTissue focuses on iPSC-based regenerative tissue products (“ready-to-use” micro-organs). The company targets the “stem cells + engineered scaffolds” intersection, developing functional micro-organ products on 3D biodegradable oriented micro-fiber scaffolds for major diseases. In January 2026, Dynamic RegeTissue raised Angel funding led by new investor Dalton Venture.
The company develops iPSC cardiac tissue sheets (multilayer iCM on 3D scaffolds, ~0.8–1.1 mm thickness, targeting severe/terminal heart failure with potential minimally invasive thoracoscopic delivery) and iPSC-derived MSC skin tissue sheets (for burns/chronic non-healing wounds such as diabetic foot ulcers, promoting angiogenesis and tissue reconstruction); it also out-licenses/partners its platform capabilities (3D scaffolds, micro-tissue construction, cardiac toxicity models) for external collaborative research and services.
Revenue comes from out-licensing/co-development, platform services (evaluation models, scaffold technologies), and commercialization of tissue-sheet products for cardiac repair and advanced wound care.

## Funding rounds

- Angel, Jan 4, 2026 — Dalton Venture

## Investors

- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Angel